An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom

An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom

Diğer sürümleri göster (1)

Background: Adjuvant! Online is an internet-based computer programme providing 10-year prognosis predictions for early breast cancer patients. It was developed in the United States, has been successfully validated in Canada, and is used in the United Kingdom and elsewhere. This study investigates th...

Detaylı Bibliyografya
Asıl Yazarlar:	Campbell, H, Taylor, M, Harris, A, Gray, A
Diğer Yazarlar:	Cancer Research UK
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Nature Publishing Group 2009
Konular:	Public Health Oncology

Benzer Materyaller

An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.
Yazar:: Campbell, H, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Peripheral T-cell lymphoma in childhood: population-based experience in the United Kingdom over 20 years
Yazar:: Windsor, R, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Adjuvant and Neoadjuvant Therapy for Breast Cancer: A Systematic Review
Yazar:: Amal Sayfuldeen Qari, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trial
Yazar:: Mark Opdam, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Predictive value of TCR Vβ-Jβ profile for adjuvant gefitinib in EGFR mutant NSCLC from ADJUVANT-CTONG 1104 trial
Yazar:: Cunte Chen, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

ToPP: Tumor online prognostic analysis platform for prognostic feature selection and clinical patient subgroup selection
Yazar:: Jian Ouyang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

Recruiting Opinion Leaders for the United Kingdom ASSIST Programme
Yazar:: Holliday, J, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis
Yazar:: Knowles, H, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma
Yazar:: Dongjiang Chen, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

Fatal case of sorafenib-associated idiosyncratic hepatotoxicity in the adjuvant treatment of a patient with renal cell carcinoma.
Yazar:: Fairfax, B, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

The adherence and tolerance of adjuvant endocrine therapy in geriatric breast cancer patients
Yazar:: Meng-Ting Peng, ve diğerleri
Baskı/Yayın Bilgisi: (2016-09-01)

Adherence status to Adjuvant Endocrine Therapy in Chinese Women with Early Breast Cancer and its influencing factors: A cross‐sectional survey
Yazar:: Hui Xu, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

Cardiovascular events and venous thromboembolism after primary malignant or non-malignant brain tumour diagnosis: a population matched cohort study in Wales (United Kingdom)
Yazar:: Michael T. C. Poon, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer
Yazar:: Eoin P. Kerin, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Yazar:: Williams, C, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy
Yazar:: C Williams, ve diğerleri
Baskı/Yayın Bilgisi: (2006-09-01)

Effectiveness of adjuvant chemotherapy for elderly patients with triple-negative breast cancer
Yazar:: Qiusheng Guo, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK.
Yazar:: Campbell, H, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications
Yazar:: Agata Bikiewicz, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/neu in breast cancer and is an independent predictor of prognosis
Yazar:: Winters, Z, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom
Yazar:: Michele A. Kohli, ve diğerleri
Baskı/Yayın Bilgisi: (2021-11-01)

Adjuvant Therapy Reduces Fat Mass Loss during Exercise Prescription in Breast Cancer Survivors
Yazar:: Gabriele Mascherini, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Effects of yoga practice on physiological distress, fatigue and QOL in patients affected by breast cancer undergoing adjuvant radiotherapy
Yazar:: Simona Micheletti, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer
Yazar:: Michalina Janiszewska, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer
Yazar:: Elizabeth Comen, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Effect of metformin on breast cancer metabolism
Yazar:: Lord, S, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer
Yazar:: Sagar Sardesai, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

Women’s Beliefs on Early Adherence to Adjuvant Endocrine Therapy for Breast Cancer: A Theory-Based Qualitative Study to Guide the Development of Community Pharmacist Interventions
Yazar:: Brittany Humphries, ve diğerleri
Baskı/Yayın Bilgisi: (2018-06-01)

Patient Preferences for Treatment in Relapsed/Refractory Acute Leukemia in the United Kingdom: A Discrete Choice Experiment
Yazar:: Mott DJ, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare.
Yazar:: Griffiths, R, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer
Yazar:: He Huang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)

Adaptation to chronic hypoxia in triple-negative breast cancer
Yazar:: Hartley, F
Baskı/Yayın Bilgisi: (2023)

DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
Yazar:: Thale Kristin Olsen, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

APAVAC Immunotherapy for the Adjuvant Treatment of a Canine Mucosal Melanoma
Yazar:: Valentina Rinaldi, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

EnROL: a multicentre randomised trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme.
Yazar:: Kennedy, R, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Prognostic fine needle aspiration biopsy of uveal melanoma: Molecular and genetic factors of metastasis risk
Yazar:: V. A. Yarovaya, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)

Breast cancer in young families: a qualitative interview study of fathers and their role and communication with their children following the diagnosis of maternal breast cancer
Yazar:: Forrest, G, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Herceptin resistance in HER2-moderately expressed breast cancer
Yazar:: Kerry, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Response and resistance to lapatinib in HER2-overexpressing breast cancer
Yazar:: Leung, W
Baskı/Yayın Bilgisi: (2014)

Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer
Yazar:: Caroline Muñoz, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)